$80.91
-1.26[-1.53%]
At close: Apr 26
$80.91
0[0.00%]
After Hours: 4:35PM EDT
Biomarin Pharmaceutical
(NASDAQ:BMRN)Biomarin Pharmaceutical Stock (NASDAQ:BMRN), Insider Trading Activity
Biomarin Pharmaceutical: Insider buying and selling updated today.
Shares Outstanding
189.777M%
Insider Shares Owned
2.462M
Insider Percentage Owned
1.30%
Institutional Shares Held
132.130M
Institutional Percentage Held
69.6%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15, 2024 | JACQUES JEAN BIENAIME | DIRECTOR | 0 | $77.11 | -$1.12M | SELL-OPTIONS | 0.00% | 475.094K | Apr 11 - Apr 12 | View |
| Apr 12, 2024 | Erin Burkhart | GVP, CHIEF ACCOUNTING OFFICER | -2.286K | $90.00 | -$205.74K | SELL | -12.40% | 16.156K | Apr 10 | View |
| Apr 01, 2024 | Eric George Davis | EVP, CHIEF LEGAL OFFICER | -24.602K | $88.34 | -$2.17M | SELL | -30.58% | 55.856K | Mar 28 | View |
| Mar 07, 2024 | HENRY FUCHS | PRESIDENT, WORLDWIDE R&D | -35.341K | $85.18 | -$3.01M | SELL | -14.28% | 212.117K | Mar 05 | View |
| Mar 07, 2024 | JACQUES JEAN BIENAIME | DIRECTOR | -2K | $86.11 | -$172.22K | SELL | -0.36% | 560.303K | Mar 05 - Mar 06 | View |
| Mar 07, 2024 | Robert Jeffrey Ajer | EVP, CHIEF COMMERCIAL OFFICER | -4K | $87.07 | -$348.28K | SELL | -4.08% | 94.047K | Mar 05 | View |
| Feb 29, 2024 | JACQUES JEAN BIENAIME | DIRECTOR | 142.601K | $90.35 | -$90.35K | GRANT | 33.98% | 562.303K | Feb 27 | View |
| Feb 12, 2024 | JACQUES JEAN BIENAIME | DIRECTOR | 40 | $76.08 | -$774.05K | SELL-OPTIONS | 0.01% | 419.702K | Jan 18 - Feb 09 | View |
| Jan 11, 2024 | JACQUES JEAN BIENAIME | DIRECTOR | 50 | $80.24 | -$678.75K | SELL-OPTIONS | 0.01% | 425.262K | Jan 08 - Jan 10 | View |
| Dec 22, 2023 | JACQUES JEAN BIENAIME | DIRECTOR | 0 | $78.55 | -$308.90K | SELL-OPTIONS | 0.00% | 425.212K | Dec 21 | View |
| Dec 14, 2023 | Eric George Davis | EVP, CHIEF LEGAL OFFICER | -13.764K | $95.30 | -$1.31M | SELL | -19.81% | 55.71K | Dec 13 | View |
| Aug 17, 2023 | Robert Jeffrey Ajer | EVP, CHIEF COMMERCIAL OFFICER | -4.682K | $78.44 | -$428.73K | SELL | -7.15% | 60.804K | Apr 28 - Aug 16 | View |
| Aug 11, 2023 | HENRY FUCHS | PRESIDENT, WORLDWIDE R&D | -12K | $90.43 | -$1.09M | SELL | -6.38% | 176.187K | Aug 10 | View |
| Aug 10, 2023 | Greg Charles Guyer | EVP, CHIEF TECHNICAL OFFICER | -5.36K | $93.30 | -$500.11K | SELL | -11.81% | 40.041K | Aug 09 | View |
| Aug 09, 2023 | Eric George Davis | EVP, CHIEF LEGAL OFFICER | -11K | $89.42 | -$983.66K | SELL | -13.67% | 69.474K | Aug 08 | View |
| Aug 09, 2023 | JACQUES JEAN BIENAIME | CHIEF EXECUTIVE OFFICER | -10K | $88.21 | -$882.14K | SELL | -2.31% | 422.832K | Aug 07 - Aug 08 | View |
| May 15, 2023 | JACQUES JEAN BIENAIME | CHIEF EXECUTIVE OFFICER | 0 | $81.24 | -$805.93K | SELL-OPTIONS | 0.00% | 426.313K | May 11 | View |
| May 11, 2023 | JACQUES JEAN BIENAIME | CHIEF EXECUTIVE OFFICER | 317 | $81.35 | -$1.60M | SELL-OPTIONS | 0.07% | 426.313K | Apr 28 - May 10 | View |
| Apr 12, 2023 | JACQUES JEAN BIENAIME | CHIEF EXECUTIVE OFFICER | 0 | $83.69 | -$317.50K | SELL-OPTIONS | 0.00% | 425.996K | Apr 10 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.